120 related articles for article (PubMed ID: 13229519)
1. [Triethylene-melamine and its combinations in therapy of hemolymphoblastosis].
MARMONT A; FUSCO F
Arch Maragliano Patol Clin; 1954; 9(5):1179-250. PubMed ID: 13229519
[No Abstract] [Full Text] [Related]
2. [Oral triethylene melamine therapy of malignant lymphogranuloma and related conditions].
VAN DER HEIDE-WESSEL C; GROEN J
Ned Tijdschr Geneeskd; 1951 Nov; 95(47):3542. PubMed ID: 14919679
[No Abstract] [Full Text] [Related]
3. [Triethylene melanine in the treatment of certain blood diseases].
PAVLOVSKY A; VILASECA GC
Sang; 1953; 24(7):578-91. PubMed ID: 13135374
[No Abstract] [Full Text] [Related]
4. [Therapy of malignant diseases of the blood with cortisone, triethylene melamine and the trace elements].
DUBOIS-FERRIERE H
Schweiz Med Wochenschr; 1951 Dec; 81(50):1235-7. PubMed ID: 14913076
[No Abstract] [Full Text] [Related]
5. [Clinical contribution to the treatment of various types of hemoblastosis with triethylene melamine].
CATTANEO O
G Ital Chemioter; 1954; 1(3-4):557-8. PubMed ID: 14391668
[No Abstract] [Full Text] [Related]
6. TRIETHYLENE-MELAMINE.
Br Med J; 1955 Jun; 1(4926):1380-1. PubMed ID: 14363905
[No Abstract] [Full Text] [Related]
7. [30 Cases of hemoblastosis and 6 cases of neoplasms of various types treated with triethylenemelamine].
STORTI E; MANZINI E
G Ital Chemioter; 1954; 1(1):116-9. PubMed ID: 13191601
[No Abstract] [Full Text] [Related]
8. [First results of therapy with triethylene melamine].
NOWOTNA-WALCOWA R
Pol Tyg Lek (Wars); 1955 Feb; 10(5):149-51. PubMed ID: 14371117
[No Abstract] [Full Text] [Related]
9. Clinical and hematologic effects of triethylene melamine.
AXELROD AR; BERMAN L; MURPHY RV
Am J Med; 1953 Nov; 15(5):684-94. PubMed ID: 13104437
[No Abstract] [Full Text] [Related]
10. Some clinical experience in the use of triethylene melamine (TEM).
HAMERMAN DJ; MELAMED S
J Mt Sinai Hosp N Y; 1953; 20(1):16-26. PubMed ID: 13061942
[No Abstract] [Full Text] [Related]
11. The immediate action of triethylene melamine in chronic lymphatic leuchaemia.
BOLTON JH; BEAN RH
Med J Aust; 1954 Sep; 2(12):474-8. PubMed ID: 13213377
[No Abstract] [Full Text] [Related]
12. [Clinical experiences with triethylene melamine in therapy of neoplastic diseases of the blood].
BOCK HE; KIRBERGER E; WOELFFER U
Z Klin Med; 1953; 150(5):482-98. PubMed ID: 13137291
[No Abstract] [Full Text] [Related]
13. [Triethylenemelamine (TEM) in lymphatic leukemia].
PRIBILLA W; STOLLBERG G
Munch Med Wochenschr; 1954 Oct; 96(41):1189-91. PubMed ID: 13223716
[No Abstract] [Full Text] [Related]
14. [Thirty cases of chronic leukemic lymphadenosis treated with intravenous administration of triethylene melamine].
GIGANTE D; ZOPPINI A
Prog Med (Napoli); 1956 Jun; 12(12):361-8. PubMed ID: 13350408
[No Abstract] [Full Text] [Related]
15. Triethylene melamine in the treatment of neoplastic disease.
RUNDLES RW; BARTON WB
Blood; 1952 May; 7(5):483-507. PubMed ID: 14925143
[No Abstract] [Full Text] [Related]
16. The clinical use of triethylene melamine.
KRAVITZ SC; DIAMOND HD; CRAVER LF
Blood; 1952 Jul; 7(7):729-42. PubMed ID: 14934758
[No Abstract] [Full Text] [Related]
17. Triethylene melamine therapy in the lymphomatous diseases.
RUNDLES RW
South Med J; 1955 Dec; 48(12):1331-4. PubMed ID: 13274172
[No Abstract] [Full Text] [Related]
18. [Triethylene melamine therapy of malignant granulomatosis and certain other malignant diseases].
HANSEN PB; BICHEL J
Nord Med; 1952 Jan; 47(2):58-61. PubMed ID: 14910945
[No Abstract] [Full Text] [Related]
19. [The therapeutic effect of triethylene melamine in hemoblastosis].
SCHULZE E; FRANKE R; THIELE FH
Arztl Wochensch; 1953 Jul; 8(29):690-4. PubMed ID: 13080055
[No Abstract] [Full Text] [Related]
20. [Therapy of malignant diseases with triethylene melamine].
ROMEO ORBEGOZO JM
Rev Clin Esp; 1953 Sep; 50(5):382-6. PubMed ID: 13134813
[No Abstract] [Full Text] [Related]
[Next] [New Search]
